FDA WARNING_LETTER - Insight Pharmaceuticals Corporation - Unknown Date

FDA WARNING_LETTER for Insight Pharmaceuticals Corporation on Unknown Date. Product: Drugs. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA WARNING_LETTER for Insight Pharmaceuticals Corporation on Unknown Date. Product: Drugs. Access full analysis and detailed observations.

Violation Codes

21 U.S.C. 331(a)

21 U.S.C. 352(a)

21 U.S.C. 353(b)(4)

21 U.S.C. 353

21 U.S.C. 321(g)(1)(B)

21 U.S.C. 331

21 U.S.C. 353(b)(1)

21 U.S.C. 352(f)(1)

21 U.S.C. 321(g)(1)(C)

21 U.S.C. 352

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Insight Pharmaceuticals Corporation

Inspection Date

Unknown Date

Product Type

Drugs

Office

Philadelphia District Office

People

Kirk D. Sooter (District Director)

ID: be60677d-6eb1-4e26-a1e6-a909d7d0a232

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox